Clinical Trial Update: LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating low-dose radiotherapy combined with toripalimab and chemotherapy for recurrent or metastatic nasopharyngeal carcinoma; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer | Phase 2 | Status: RECRUITING